219 related articles for article (PubMed ID: 26286506)
1. Protocol for a systematic review: understanding the motivations and barriers to uptake and use of female-initiated, primary biomedical HIV prevention technologies in sub-Saharan Africa.
Eakle R; Jarrett C; Bourne A; Stadler J; Larson H
Syst Rev; 2015 Aug; 4():111. PubMed ID: 26286506
[TBL] [Abstract][Full Text] [Related]
2. Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography.
Eakle R; Bourne A; Jarrett C; Stadler J; Larson H
BMC Public Health; 2017 Dec; 17(1):968. PubMed ID: 29258455
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
Govender EM; Mansoor LE; Abdool Karim Q
AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
[TBL] [Abstract][Full Text] [Related]
5. Differentiated models of service delivery for antiretroviral treatment of HIV in sub-Saharan Africa: a rapid review protocol.
Long L; Kuchukhidze S; Pascoe S; Nichols B; Cele R; Govathson C; Huber A; Flynn D; Rosen S
Syst Rev; 2019 Dec; 8(1):314. PubMed ID: 31810482
[TBL] [Abstract][Full Text] [Related]
6. Women and ARV-based HIV prevention - challenges and opportunities.
Geary CW; Bukusi EA
J Int AIDS Soc; 2014; 17(3 Suppl 2):19356. PubMed ID: 25224621
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
Murewanhema G; Malisheni M; Takah NF
Pan Afr Med J; 2021; 38():308. PubMed ID: 34178226
[TBL] [Abstract][Full Text] [Related]
8. HIV Pre-Exposure Prophylaxis Uptake Among High-Risk Population in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Nagai H; Ankomah A; Fuseini K; Adiibokah E; Semahegn A; Tagoe H
AIDS Patient Care STDS; 2024 Feb; 38(2):70-81. PubMed ID: 38381951
[TBL] [Abstract][Full Text] [Related]
9. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
[TBL] [Abstract][Full Text] [Related]
10. Barriers to and enablers of uptake of and adherence to antiretroviral therapy in the context of integrated HIV and tuberculosis treatment among adults in sub-Saharan Africa: a protocol for a systematic literature review.
Momo Kadia B; Takah NF; Akem Dimala C; Smith A
BMJ Open; 2019 Oct; 9(10):e031789. PubMed ID: 31662398
[TBL] [Abstract][Full Text] [Related]
11. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
Eakle R; Weatherburn P; Bourne A
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429
[TBL] [Abstract][Full Text] [Related]
12. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.
Gourlay A; Birdthistle I; Mburu G; Iorpenda K; Wringe A
J Int AIDS Soc; 2013 Jul; 16(1):18588. PubMed ID: 23870277
[TBL] [Abstract][Full Text] [Related]
13. Service delivery models that promote linkages to PrEP for adolescent girls and young women and men in sub-Saharan Africa: a scoping review.
Ramraj T; Chirinda W; Jonas K; Govindasamy D; Jama N; McClinton Appollis T; Zani B; Mukumbang FC; Basera W; Hlongwa M; Turawa EB; Mathews C; Nicol E
BMJ Open; 2023 Mar; 13(3):e061503. PubMed ID: 36972966
[TBL] [Abstract][Full Text] [Related]
14. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
McGillen JB; Anderson SJ; Hallett TB
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
[TBL] [Abstract][Full Text] [Related]
15. Reaching at-risk women for PrEP delivery: What can we learn from clinical trials in sub-Saharan Africa?
Stankevitz K; Schwartz K; Hoke T; Li Y; Lanham M; Mahaka I; Mullick S
PLoS One; 2019; 14(6):e0218556. PubMed ID: 31226165
[TBL] [Abstract][Full Text] [Related]
16. Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial.
Nash S; Dietrich J; Ssemata AS; Herrera C; O'Hagan K; Else L; Chiodi F; Kelly C; Shattock R; Chirenje M; Lebina L; Khoo S; Bekker LG; Weiss HA; Gray C; Stranix-Chibanda L; Kaleebu P; Seeley J; Martinson N; Fox J;
Trials; 2020 Oct; 21(1):900. PubMed ID: 33121503
[TBL] [Abstract][Full Text] [Related]
17. Impact of approaches in improving male partner involvement in the prevention of mother-to-child transmission (PMTCT) of HIV on the uptake of PMTCT services in sub-Saharan Africa: a protocol of a systematic review and meta-analysis.
Takah NF; Kennedy IT; Johnman C
BMJ Open; 2016 Jul; 6(7):e012224. PubMed ID: 27371555
[TBL] [Abstract][Full Text] [Related]
18. HIV pre-exposure prophylaxis uptake, retention and adherence among female sex workers in sub-Saharan Africa: a systematic review.
Mpirirwe R; Segawa I; Ojiambo KO; Kamacooko O; Nangendo J; Semitala FC; Kyambadde P; Kalyango JN; Kiragga A; Karamagi C; Katahoire A; Kamya M; Mujugira A
BMJ Open; 2024 Apr; 14(4):e076545. PubMed ID: 38670600
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in HIV testing among elders in Sub-Saharan Africa: a systematic review protocol.
Gebremeskel AT; Omonaiye O; Yaya S
Syst Rev; 2022 May; 11(1):95. PubMed ID: 35578357
[TBL] [Abstract][Full Text] [Related]
20. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.
Vickerman P; Quaife M; Kilbourne-Brook M; Mvundura M; Eakle R; Terris-Prestholt F
BMC Infect Dis; 2020 Sep; 20(1):704. PubMed ID: 32977745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
